{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T07:24:51Z","timestamp":1790407491533,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.bulcan.2017.08.003","type":"journal-article","created":{"date-parts":[[2017,9,8]],"date-time":"2017-09-08T09:02:36Z","timestamp":1504861356000},"page":"892-901","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Ganglion sentinelle et chimioth\u00e9rapie n\u00e9oadjuvante dans le cancer du sein"],"prefix":"10.1016","volume":"104","author":[{"given":"Martha","family":"Duraes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eug\u00e9nie","family":"Guillot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Seror","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Pouget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Rouzier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.bulcan.2017.08.003_bib0230","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel lymph node resection compared with conventional axillary lymph node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP-B-32\u00a0randomised phase 3\u00a0trial","volume":"11","author":"Krag","year":"2010","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.bulcan.2017.08.003_bib0235","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.gyobfe.2016.04.010","article-title":"Assessment of sentinel lymph node biopsy in patients receiving neoadjuvant chemotherapy in breast cancer: before or after?","volume":"44","author":"Coutant","year":"2016","journal-title":"Gynecol Obstet Fertil"},{"issue":"6","key":"10.1016\/j.bulcan.2017.08.003_bib0240","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/jso.21128","article-title":"Timing of sentinel lymph node biopsy in patients receiving neoadjuvant chemotherapy for breast cancer","volume":"98","author":"Papa","year":"2008","journal-title":"J Surg Oncol"},{"issue":"8","key":"10.1016\/j.bulcan.2017.08.003_bib0245","first-page":"851","article-title":"Lymphatic mapping in patients with primary or recurrent breast cancer following previous axillary surgery","volume":"34","author":"Schrenk","year":"2008","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"issue":"9","key":"10.1016\/j.bulcan.2017.08.003_bib0250","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.ejso.2008.11.002","article-title":"Sentinel lymphadenectomy for the staging of clinical axillary node-negative breast cancer before neoadjuvant chemotherapy","volume":"35","author":"Menard","year":"2009","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"10.1016\/j.bulcan.2017.08.003_bib0255","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel lymph node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.bulcan.2017.08.003_bib0260","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11912-013-0364-y","article-title":"Timing of determining axillary lymph node status when neoadjuvant chemotherapy is used","volume":"16","author":"Mamounas","year":"2014","journal-title":"Curr Oncol Rep"},{"issue":"32","key":"10.1016\/j.bulcan.2017.08.003_bib0265","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1200\/JCO.2011.40.8369","article-title":"Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18\u00a0and B-27","volume":"30","author":"Mamounas","year":"2012","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.bulcan.2017.08.003_bib0270","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ejso.2006.09.032","article-title":"Assessment of clinical palpation of the axilla as a criterion for performing the sentinel node procedure in breast cancer","volume":"33","author":"Lanng","year":"2007","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.bulcan.2017.08.003_bib0275","series-title":"Cancer du sein infiltrant non m\u00e9tastatique \u2013\u00a0Questions d\u2019actualit\u00e9s\u2013Rapport int\u00e9gral\u00a9","author":"Inca","year":"2012"},{"issue":"3","key":"10.1016\/j.bulcan.2017.08.003_bib0280","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1245\/s10434-010-1347-y","article-title":"Impact of preoperative ultrasonography and fine-needle aspiration of axillary lymph nodes on surgical management of primary breast cancer","volume":"18","author":"Park","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.bulcan.2017.08.003_bib0285","doi-asserted-by":"crossref","first-page":"441","DOI":"10.4048\/jbc.2012.15.4.441","article-title":"The effects of preoperative (18)F-FDG PET\/CT in breast cancer patients in comparison to the conventional imaging study","volume":"15","author":"Choi","year":"2012","journal-title":"J Breast Cancer"},{"issue":"12","key":"10.1016\/j.bulcan.2017.08.003_bib0290","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1200\/JCO.2005.05.188","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27","volume":"23","author":"Mamounas","year":"2005","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.bulcan.2017.08.003_bib0295","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1200\/JCO.2008.18.3228","article-title":"Sentinel lymph node biopsy after neoadjuvant chemotherapy for advanced breast cancer: results of Ganglion Sentinelle et Chimiotherapie Neoadjuvante, a French prospective multicentric study","volume":"27","author":"Classe","year":"2009","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.bulcan.2017.08.003_bib0300","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/bjs.5209","article-title":"Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer","volume":"93","author":"Xing","year":"2006","journal-title":"Br J Surg"},{"issue":"5","key":"10.1016\/j.bulcan.2017.08.003_bib0305","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.acra.2009.01.026","article-title":"Breast cancer sentinel node identification and classification after neoadjuvant chemotherapy \u2013\u00a0systematic review and meta-analysis","volume":"16","author":"Kelly","year":"2009","journal-title":"Acad Radiol"},{"issue":"2","key":"10.1016\/j.bulcan.2017.08.003_bib0310","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ijc.29644","article-title":"Sentinel node biopsy performance after neoadjuvant chemotherapy in locally advanced breast cancer: a systematic review and meta-analysis","volume":"138","author":"Mocellin","year":"2016","journal-title":"Int J Cancer"},{"issue":"10","key":"10.1016\/j.bulcan.2017.08.003_bib0315","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1245\/s10434-007-9403-y","article-title":"Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation","volume":"14","author":"Newman","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.bulcan.2017.08.003_bib0320","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/cncr.22540","article-title":"Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases","volume":"109","author":"Shen","year":"2007","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.bulcan.2017.08.003_bib0325","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1245\/s10434-012-2484-2","article-title":"The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer","volume":"19","author":"Alvarado","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"14","key":"10.1016\/j.bulcan.2017.08.003_bib0330","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the American College of Surgeons Oncology Group (ACOSOG) Z1071\u00a0clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.bulcan.2017.08.003_bib0335","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study","volume":"33","author":"Boileau","year":"2015","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.bulcan.2017.08.003_bib0340","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/SLA.0000000000001375","article-title":"Identification and resection of clipped node decreases the false-negative rate of sentinel lymph node surgery in patients presenting with node-positive breast cancer (T0-T4, N1-N2) who receive neoadjuvant chemotherapy: results from ACOSOG Z1071 (Alliance)","volume":"263","author":"Boughey","year":"2016","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.bulcan.2017.08.003_bib0345","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12282-011-0323-0","article-title":"Predictive value of FDG PET\/CT for pathologic axillary node involvement after neoadjuvant chemotherapy","volume":"20","author":"Keam","year":"2013","journal-title":"Breast Cancer Tokyo Jpn"},{"issue":"4","key":"10.1016\/j.bulcan.2017.08.003_bib0350","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/jamaoncol.2015.4935","article-title":"Ten-year outcomes of patients with breast cancer with cytologically confirmed axillary lymph node metastases and pathologic complete response after primary systemic chemotherapy","volume":"2","author":"Mougalian","year":"2016","journal-title":"JAMA Oncol"},{"issue":"13","key":"10.1016\/j.bulcan.2017.08.003_bib0355","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1200\/JCO.2013.54.1177","article-title":"Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology Clinical Practice Guideline Update","volume":"32","author":"Lyman","year":"2014","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2017.08.003_bib0360","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.amjsurg.2012.10.025","article-title":"The response to neoadjuvant chemotherapy predicts clinical outcome and increases breast conservation in advanced breast cancer","volume":"206","author":"Spanheimer","year":"2013","journal-title":"Am J Surg"},{"issue":"13","key":"10.1016\/j.bulcan.2017.08.003_bib0365","first-page":"2284","article-title":"Towards rational axillary treatment in relation to neoadjuvant therapy in breast cancer","volume":"45","author":"Straver","year":"2009","journal-title":"Eur J Cancer 1990"},{"issue":"4","key":"10.1016\/j.bulcan.2017.08.003_bib0370","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1053\/ejso.2002.1404","article-title":"Different responses to preoperative chemotherapy for invasive lobular and invasive ductal breast carcinoma","volume":"29","author":"Cocquyt","year":"2003","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.bulcan.2017.08.003_bib0375","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ejso.2015.11.019","article-title":"Sentinel node biopsy after neoadjuvant treatment in breast cancer: five-year follow-up of patients with clinically node-negative or node-positive disease before treatment","volume":"42","author":"Galimberti","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.bulcan.2017.08.003_bib0380","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.clbc.2016.02.009","article-title":"Feasibility and prognostic effect of sentinel lymph node biopsy after neoadjuvant chemotherapy in cytology-proven, node-positive breast cancer","volume":"16","author":"Park","year":"2016","journal-title":"Clin Breast Cancer"},{"issue":"17","key":"10.1016\/j.bulcan.2017.08.003_bib0385","doi-asserted-by":"crossref","first-page":"24848","DOI":"10.18632\/oncotarget.6664","article-title":"The role of postmastectomy radiotherapy in clinically node-positive, stage II\u2013III breast cancer patients with pathological negative nodes after neoadjuvant chemotherapy: an analysis from the NCDB","volume":"7","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"issue":"23","key":"10.1016\/j.bulcan.2017.08.003_bib0390","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1200\/JCO.2004.11.129","article-title":"Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy","volume":"22","author":"Huang","year":"2004","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"2","key":"10.1016\/j.bulcan.2017.08.003_bib0395","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ijrobp.2009.08.053","article-title":"Is regional lymph node irradiation necessary in stage II to III breast cancer patients with negative pathologic node status after neoadjuvant chemotherapy?","volume":"78","author":"Daveau","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"16","key":"10.1016\/j.bulcan.2017.08.003_bib0400","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa022152","article-title":"Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer","volume":"347","author":"Fisher","year":"2002","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.bulcan.2017.08.003_bib0405","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/cncr.24174","article-title":"Impact of axillary lymph node dissection on breast cancer outcome in clinically node-negative patients: a systematic review and meta-analysis","volume":"115","author":"Sanghani","year":"2009","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.bulcan.2017.08.003_bib0410","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs. no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.bulcan.2017.08.003_bib0415","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/SLA.0000000000001863","volume":"264","author":"Giuliano","year":"2016","journal-title":"Ann Surg"},{"issue":"34","key":"10.1016\/j.bulcan.2017.08.003_bib0420","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1200\/JCO.2011.36.1667","article-title":"Positive sentinel nodes without axillary dissection: implications for the radiation oncologist","volume":"29","author":"Haffty","year":"2011","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2017.08.003_bib0425","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijrobp.2004.04.065","article-title":"Analysis of axillary coverage during tangential radiation therapy to the breast","volume":"61","author":"Reznik","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"996","key":"10.1016\/j.bulcan.2017.08.003_bib0430","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1259\/bjr\/25788274","article-title":"Coverage of axillary lymph nodes with high tangential fields in breast radiotherapy","volume":"83","author":"Al\u00e7o","year":"2010","journal-title":"Br J Radiol"},{"issue":"6","key":"10.1016\/j.bulcan.2017.08.003_bib0435","doi-asserted-by":"crossref","first-page":"vi7","DOI":"10.1093\/annonc\/mdt284","article-title":"Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Senkus","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bulcan.2017.08.003_bib0440","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s10269-013-2339-x","article-title":"L\u2019exploration et le traitement de la r\u00e9gion axillaire des tumeurs infiltrantes du sein (RPC Nice-Saint-Paul-de-Vence 2013). Partie III\u00a0\u2013\u00a0Technique du ganglion sentinelle et chimioth\u00e9rapie n\u00e9oadjuvante","volume":"15","author":"Classe","year":"2013","journal-title":"Oncologie"},{"key":"10.1016\/j.bulcan.2017.08.003_bib0445","series-title":"Breast cancer (Version, 2, 2017) [Internet]","author":"National Comprehensive Cancer Network","year":"2017"},{"key":"10.1016\/j.bulcan.2017.08.003_bib0225","unstructured":"Lavou\u00e9 V, Morcel K, Tas P, Bendavid C, Rouquette S, Foucher F, et al.,Tumorectomie et ganglion sentinelle. [Internet]. Paris: Vigot; 2010. [Available from: http:\/\/www.cngof.asso.fr\/d_livres\/2010_GO_323_lavoue.pdf. Consult\u00e9 le 28 juin 2017]"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455117302229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455117302229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T08:37:14Z","timestamp":1602923834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455117302229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0007455117302229"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2017.08.003","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ganglion sentinelle et chimioth\u00e9rapie n\u00e9oadjuvante dans le cancer du sein","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2017.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}